Sex-Specific Computational Models of Kidney Function in Patients With Diabetes

Sex-Specific Computational Models of Kidney Function in Patients With Diabetes

The kidney plays an essential role in homeostasis, accomplished through the regulation of pH, electrolytes and fluids, by the building blocks of the kidney, the nephrons. One of the important markers of the proper functioning of a kidney is the glomerular filtration rate. Diabetes is characterized b...

Full description

Bibliographic Details
Main Authors:	Sangita Swapnasrita, Aurélie Carlier, Anita T. Layton
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Physiology
Subjects:	sex differences diabetes mellitus SGLT2 inhibitors diuresis natriuresis kaliuresis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphys.2022.741121/full

Similar Items

A Computational Model of Kidney Function in a Patient with Diabetes
by: Rui Hu, et al.
Published: (2021-05-01)

Does plasma ANP participate in natriuresis induced by <FONT FACE=Symbol>a</font>-MSH?
by: D.L.W. Picanço-Diniz, et al.
Published: (1997-04-01)

Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetes
by: Shin Kawasoe, et al.
Published: (2017-04-01)

Genetic Deletion of P2Y2 Receptor Offers Long-Term (5 Months) Protection Against Lithium-Induced Polyuria, Natriuresis, Kaliuresis, and Collecting Duct Remodeling and Cell Proliferation
by: Yue Zhang, et al.
Published: (2018-12-01)

Diuretic and Natriuretic Effects of Hesperidin, a Flavanone Glycoside, in Female and Male Hypertensive Rats
by: Priscila de Souza, et al.
Published: (2022-12-01)

Urine sodium concentration after intravenous furosemide in dogs with acute congestive heart failure and correlation with treatment efficacy
by: Victoria Convey, et al.
Published: (2024-01-01)

Effects of phenylbutazone, firocoxib, and dipyrone on the diuretic response to furosemide in horses
by: Julianne M. White, et al.
Published: (2023-11-01)

Sex and species differences in epithelial transport in rat and mouse kidneys: Modeling and analysis
by: Melissa Maria Stadt, et al.
Published: (2022-09-01)

Influence of renal denervation on blood pressure, sodium and water excretion in acute total obstructive apnea in rats
by: J.V.M. Franquini, et al.
Published: (2009-02-01)

Endothelin mediates sex-differences in acclimation to high salt diet in rats
by: Victoria L. Nasci, et al.
Published: (2023-10-01)

Evaluation of Diuretic Activity of Aqueous and Hydro Methanolic Crude Extracts and Solvent Fraction of the Hydromethanolic Flower Extract of Erica Arborea L. (Ericaceae) in Swiss Albino Mice
by: Wondimu NL, et al.
Published: (2024-04-01)

Unlocking the Potential of Acetazolamide: A Literature Review of an Adjunctive Approach in Heart Failure Management
by: Michael Sabina, et al.
Published: (2024-01-01)

Albumin and Furosemide Combination for Management of Edema in Nephrotic Syndrome: A Review of Clinical Studies
by: Margaret Duffy, et al.
Published: (2015-10-01)

Impairment of natriuresis and diuresis induced by intrarenal adrenoceptor mechanisms in an experimental model of cirrhosis in rats
by: Maycon I.O. Milanez, et al.
Published: (2019-12-01)

Acclimation to a High‐Salt Diet Is Sex Dependent
by: Eman Y. Gohar, et al.
Published: (2022-03-01)

Anti-hypertensive effect of a novel angiotensin II receptor neprilysin inhibitor (ARNi) -S086 in DSS rat model
by: Jingchao Sun, et al.
Published: (2024-02-01)

Natriuresis as a Way to Assess the Effectiveness of Diuretic Therapy for Acute Decompensated Heart Failure: Data from a Pilot Study
by: K. V. Charaya, et al.
Published: (2023-01-01)

Hypokalemic Quadriparesis: An Unusual Manifestation of Leptospirosis
by: Mahendran K., et al.
Published: (2014-01-01)

Effect of SGLT2 inhibitors on the course of chronic heart failure in patients with type 2 diabetes mellitus
by: A. N. Payudis, et al.
Published: (2022-10-01)

EFFECT OF SACUBITRIL/VALSARTAN ON NATRIURESIS, DIURESIS AND BLOOD PRESSURE IN HYPERTENSIVE PATIENTS
by: Zh. D. Kobalava, et al.
Published: (2017-07-01)

Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease
by: Merita Rroji, et al.
Published: (2024-03-01)

Neuroendocrine regulation of salt and water metabolism
by: S.M. McCann, et al.
Published: (1997-04-01)

Comparison of cardiovascular outcomes between SGLT2 inhibitors in diabetes mellitus
by: Yuta Suzuki, et al.
Published: (2022-05-01)

The effect of NADP on some values of the renal acid-regulating function at experimental diabetes melli
by: M. I. Grytsiuk
Published: (2017-11-01)

The effect of NADP on some values of the renal acid-regulating function at experimental diabetes melli
by: M. I. Grytsiuk
Published: (2017-11-01)

Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
by: Panagiotis Theofilis, et al.
Published: (2023-02-01)

Cardiovascular Disease in Diabetes and Chronic Kidney Disease
by: Sowmya Swamy, et al.
Published: (2023-11-01)

SGLT2 Inhibitors in Chronic Kidney Disease: From Mechanisms to Clinical Practice
by: Roko Skrabic, et al.
Published: (2022-10-01)

Sex differences in cardiovascular outcomes of SGLT-2 inhibitors in heart failure randomized controlled trials: A systematic review and meta-analysis
by: Frederick Berro Rivera, et al.
Published: (2023-02-01)

Quantifying the integrated physiological effects of endothelin-1 on cardiovascular and renal function in healthy subjects: a mathematical modeling analysis
by: Hongtao Yu, et al.
Published: (2024-04-01)

How the kidney regulates magnesium: a modelling study
by: Pritha Dutta, et al.
Published: (2024-03-01)

The Role of Nitric Oxide in the Dysregulation of the Urine Concentration Mechanism in Diabetes Mellitus
by: Penelope eCipriani, et al.
Published: (2012-06-01)

Euglycemic diabetic ketoacidosis associated with SGLT2 inhibitors: A systematic review and quantitative analysis
by: Siddhartha Dutta, et al.
Published: (2022-01-01)

SGLT2 Inhibitors and Kidney Outcomes in Patients with Chronic Kidney Disease
by: Swetha R. Kanduri, et al.
Published: (2020-08-01)

Gliflozins position update in the treatment algorithms for patients with type 2 diabetes mellitus and chronic kidney disease: new pathogenetic mechanisms and data from subanalyses of the large randomised control trails
by: O. Y. Sukhareva, et al.
Published: (2022-02-01)

Impact of SGLT-2 inhibitors on modifiable cardiovascular risk factors in Romanian patients with type 2 diabetes mellitus
by: Adriana Gherbon, et al.
Published: (2024-04-01)

Comparative safety of sodium-glucose co-transporter 2 inhibitors in elderly patients with type 2 diabetes mellitus and diabetic kidney disease: a systematic review and meta-analysis
by: Yi Liu, et al.
Published: (2023-12-01)

Severe euglycemic diabetic ketoacidosis of multifactorial etiology in a type 2 diabetic patient treated with empagliflozin: case report and literature review
by: Erasmia Sampani, et al.
Published: (2020-07-01)

Sodium glucose co-transporter 2 inhibitors in heart failure therapy
by: Yüksel Çavuşoğlu, et al.
Published: (2020-04-01)

Effect of sodium glucose cotransporter 2 inhibitors on cardiac function and cardiovascular outcome: a systematic review
by: Koichiro Matsumura, et al.
Published: (2019-11-01)